BioAdaptives, Inc. Redefines Its Expanding Role of Providing Innovative Human Health Products While Its Wholly Owned Subsidiary, LiveStock Impact, Inc., Targets Animal Health and Botanical Drugs

LAS VEGAS, NV, Sept. 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – BioAdaptives, Inc. (OTCMkts:  BDPT) announced today new directions and activities intended to expand the Company’s role in providing additional products for human health.  Besides continuing to develop and market novel all natural supplement formulations for general use, BDPT is developing potential products that are designed to benefit more specific sectors such as Women’s and Men’s Health.  Additional expansion under consideration includes the marketing of natural topical formulations based upon current ongoing research and certain functional foods with demonstrated health benefits.

BioAdaptives’ wholly owned subsidiary, LiveStock Impact, Inc., will focus on two commercial activities: animal health and botanical drugs. The Company will continue to market its current popular Equine and Canine products while developing new natural formulations under the guidance of experienced new Directors, Bruce Colclasure and Dr. Charles Timmerman, D.V.M.  In addition, with the new realigned functions and products, where botanical drugs development being a LiveStock Impact, Inc. function, Dr. Yagang Liu and Dr. David Allen have now joined the Board of Directors of LiveStock Impact, Inc. and resigned from BioAdaptives, Inc. Their anticipated contribution to the development of various botanical drugs, including several patented by Dr. Liu, would be much valued here. 

Edward Jacobs, M.D., CEO of BioAdaptives,Inc., comments, “We are very pleased that the timely separation and delineation of activities for each of the two companies is in concert with the appointments of new Directors with individual relevant expertise.

“Although the separation of these areas is designed to be efficient, we know that there is a common benefit for everyone because of the inherent and continual cross-over of knowledge among human and animal health endeavors.  We continue to reach out to potential domestic and international collaborators to build a more diverse and global enterprise.” 

About BioAdaptives, Inc.

BioAdaptives, Inc. manufactures and distributes natural plant- and algal-based products that improve health and wellness for humans and animals, with an emphasis on optimizing pain relief, anti-viral activity, and immune system defense; resistance to stress; endurance; recovery from injury, illness, and exercise; and anti-aging properties.  The Company’s current dietary supplement formulations are carefully selected from the best world-wide sources and utilize proprietary methods of enhancing the bioavailability of nutrients. The current product line includes PrimiLungs, PluriPain, SleepEZ, MindnMemory and Cell Rejuven for humans.